Following the launch of the UPC earlier this year, the Life Sciences Strategy Summit on IP & Exclusivity (10-11 October | Munich) is connecting the leading figures in the life sciences IP space and those operating within the new system, for two-days of candid discussions exploring the industry’s reaction to the court and the latest around patent strategy, patent prosecution and market exclusivity topics.
Find out more about why 150+ industry, judicial, regulatory and private practice legal representatives are getting involved here: https://hubs.ly/Q01YPMbM0 or email This email address is being protected from spambots. You need JavaScript enabled to view it.